Jianmei Kochling received her PhD from Northeastern University.
She is responsible for analyticalcharacterization support for commercial product comparability studies, release,process improvement, manufacturing investigations for therapeutic proteins andmonoclonal antibodies. She is also responsible for developing analytical methodsfor product release and stability testing in support of analytical life cyclemanagement with quality by design and up-to-date technologies. Prior to thisposition, she was a director at the Quality Control Technical Service and a scientificassociate director at Analytical R&D of Sanofi Genzyme. She has successfully ledseveral programs in analytical development at different clinical phases, includingsuccessful commercial launches for an oral dosage drug (Cerdelga) and a parenteraldrug (Plenaxis). She has worked at several Pharmaceutical and Biopharmaceutical companies, heldvarious positions with increasing responsibilities.She has also been actively serving AAPS with leadership roles in the past 10 years.
会议日程:
上一篇:CABS 2020 BioPacific Conference Passion for Better Medicine 下一篇:2020 DIA药物信息年会暨展览会